These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 11352337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
    Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM.
    J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
    [Abstract] [Full Text] [Related]

  • 3. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U, Arató M, Zhu Y, Austin C.
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [Abstract] [Full Text] [Related]

  • 4. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M.
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [Abstract] [Full Text] [Related]

  • 5. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
    Russell JM, Koran LM, Rush J, Hirschfeld RM, Harrison W, Friedman ES, Davis S, Keller M.
    Depress Anxiety; 2001 Dec; 13(1):18-27. PubMed ID: 11233456
    [Abstract] [Full Text] [Related]

  • 11. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
    Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME.
    J Clin Psychiatry; 1998 Nov; 59(11):589-97. PubMed ID: 9862605
    [Abstract] [Full Text] [Related]

  • 12. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
    Friedli K, Guirguis A, Almond M, Day C, Chilcot J, Da Silva-Gane M, Davenport A, Fineberg NA, Spencer B, Wellsted D, Farrington K.
    Clin J Am Soc Nephrol; 2017 Feb 07; 12(2):280-286. PubMed ID: 28126706
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P, Scapicchio P, Chiaie RD.
    Int J Neuropsychopharmacol; 2002 Dec 07; 5(4):287-94. PubMed ID: 12466028
    [Abstract] [Full Text] [Related]

  • 14. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
    Tignol J, Pujol-Domenech J, Chartres JP, Léger JM, Plétan Y, Tonelli I, Tournoux A, Pezous N.
    Acta Psychiatr Scand; 1998 Feb 07; 97(2):157-65. PubMed ID: 9517912
    [Abstract] [Full Text] [Related]

  • 15. Switching from imipramine to sertraline in panic disorder.
    Mavissakalian MR.
    J Psychiatr Pract; 2004 Mar 07; 10(2):88-94. PubMed ID: 15330404
    [Abstract] [Full Text] [Related]

  • 16. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb 07; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 17. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW, Su TP, Huang CY, Chen YS, Chou YH.
    J Clin Psychopharmacol; 2011 Oct 07; 31(5):577-81. PubMed ID: 21869697
    [Abstract] [Full Text] [Related]

  • 18. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ.
    J Clin Psychiatry; 1998 Dec 07; 59(12):669-75. PubMed ID: 9921701
    [Abstract] [Full Text] [Related]

  • 19. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB, Plosker GL, Noble S.
    Drugs Aging; 2002 Dec 07; 19(5):377-92. PubMed ID: 12093324
    [Abstract] [Full Text] [Related]

  • 20. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, Toto RD, Trivedi MH.
    JAMA; 2017 Nov 21; 318(19):1876-1890. PubMed ID: 29101402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.